0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oral Solid Dosage Manufacturing Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-11N15442
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oral Solid Dosage Manufacturing Market Insights Forecast to 2029
BUY CHAPTERS

Global Oral Solid Dosage Manufacturing Market Research Report 2025

Code: QYRE-Auto-11N15442
Report
January 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oral Solid Dosage Manufacturing Market

The global market for Oral Solid Dosage Manufacturing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Oral solid dosage manufacturing refers to the process of producing pharmaceutical products in solid form that are intended to be taken orally, such as tablets, capsules, and powders. This manufacturing process involves several steps, including formulation development, blending, granulation, compression, coating, and packaging.
Formulation development is the initial stage where the active pharmaceutical ingredient (API) and other excipients are selected and combined to create a stable and effective dosage form. Blending involves mixing the API and excipients to ensure uniform distribution of the drug throughout the dosage form. Granulation is the process of forming granules from the blended mixture to improve flowability and compressibility.
Compression is the step where the granules are compressed into tablets or filled into capsules using specialized equipment. Coating may be applied to tablets to improve appearance, taste, and stability, as well as to control the release of the drug. Finally, the finished dosage forms are packaged in appropriate containers, such as blister packs or bottles, and labeled for distribution.
Oral solid dosage manufacturing requires strict adherence to Good Manufacturing Practices (GMP) to ensure the quality, safety, and efficacy of the pharmaceutical products. This includes maintaining a controlled manufacturing environment, conducting regular quality control testing, and following standard operating procedures to prevent contamination and ensure consistency in the manufacturing process.
North American market for Oral Solid Dosage Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Oral Solid Dosage Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Oral Solid Dosage Manufacturing in Drug Formulation Development is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Oral Solid Dosage Manufacturing include CRB, LGM Pharma, Pfizer, Piramal Group, Avara Pharmaceutical Services, Alcami, Thermo Fisher Scientific, Recipharm, Metrics Contract Services, BOC Sciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oral Solid Dosage Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Solid Dosage Manufacturing.
The Oral Solid Dosage Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Solid Dosage Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Solid Dosage Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Oral Solid Dosage Manufacturing Market Report

Report Metric Details
Report Name Oral Solid Dosage Manufacturing Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CRB, LGM Pharma, Pfizer, Piramal Group, Avara Pharmaceutical Services, Alcami, Thermo Fisher Scientific, Recipharm, Metrics Contract Services, BOC Sciences, Societal CDMO, DFE Pharma, NNE, Pharma Access
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Oral Solid Dosage Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Oral Solid Dosage Manufacturing Market report?

Ans: The main players in the Oral Solid Dosage Manufacturing Market are CRB, LGM Pharma, Pfizer, Piramal Group, Avara Pharmaceutical Services, Alcami, Thermo Fisher Scientific, Recipharm, Metrics Contract Services, BOC Sciences, Societal CDMO, DFE Pharma, NNE, Pharma Access

What are the Application segmentation covered in the Oral Solid Dosage Manufacturing Market report?

Ans: The Applications covered in the Oral Solid Dosage Manufacturing Market report are Drug Formulation Development, Formulation Production

What are the Type segmentation covered in the Oral Solid Dosage Manufacturing Market report?

Ans: The Types covered in the Oral Solid Dosage Manufacturing Market report are Wet Granulation, Dry Granulation, Direct Compression, Particle Coating, Other

Recommended Reports

Oral Dosage Forms

Pharma Packaging

Pharmaceutical Excipients

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Solid Dosage Manufacturing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Wet Granulation
1.2.3 Dry Granulation
1.2.4 Direct Compression
1.2.5 Particle Coating
1.2.6 Other
1.3 Market by Application
1.3.1 Global Oral Solid Dosage Manufacturing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Formulation Development
1.3.3 Formulation Production
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Solid Dosage Manufacturing Market Perspective (2020-2031)
2.2 Global Oral Solid Dosage Manufacturing Growth Trends by Region
2.2.1 Global Oral Solid Dosage Manufacturing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oral Solid Dosage Manufacturing Historic Market Size by Region (2020-2025)
2.2.3 Oral Solid Dosage Manufacturing Forecasted Market Size by Region (2026-2031)
2.3 Oral Solid Dosage Manufacturing Market Dynamics
2.3.1 Oral Solid Dosage Manufacturing Industry Trends
2.3.2 Oral Solid Dosage Manufacturing Market Drivers
2.3.3 Oral Solid Dosage Manufacturing Market Challenges
2.3.4 Oral Solid Dosage Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Solid Dosage Manufacturing Players by Revenue
3.1.1 Global Top Oral Solid Dosage Manufacturing Players by Revenue (2020-2025)
3.1.2 Global Oral Solid Dosage Manufacturing Revenue Market Share by Players (2020-2025)
3.2 Global Oral Solid Dosage Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oral Solid Dosage Manufacturing Revenue
3.4 Global Oral Solid Dosage Manufacturing Market Concentration Ratio
3.4.1 Global Oral Solid Dosage Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Solid Dosage Manufacturing Revenue in 2024
3.5 Global Key Players of Oral Solid Dosage Manufacturing Head office and Area Served
3.6 Global Key Players of Oral Solid Dosage Manufacturing, Product and Application
3.7 Global Key Players of Oral Solid Dosage Manufacturing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Solid Dosage Manufacturing Breakdown Data by Type
4.1 Global Oral Solid Dosage Manufacturing Historic Market Size by Type (2020-2025)
4.2 Global Oral Solid Dosage Manufacturing Forecasted Market Size by Type (2026-2031)
5 Oral Solid Dosage Manufacturing Breakdown Data by Application
5.1 Global Oral Solid Dosage Manufacturing Historic Market Size by Application (2020-2025)
5.2 Global Oral Solid Dosage Manufacturing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oral Solid Dosage Manufacturing Market Size (2020-2031)
6.2 North America Oral Solid Dosage Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oral Solid Dosage Manufacturing Market Size by Country (2020-2025)
6.4 North America Oral Solid Dosage Manufacturing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Solid Dosage Manufacturing Market Size (2020-2031)
7.2 Europe Oral Solid Dosage Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oral Solid Dosage Manufacturing Market Size by Country (2020-2025)
7.4 Europe Oral Solid Dosage Manufacturing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Solid Dosage Manufacturing Market Size (2020-2031)
8.2 Asia-Pacific Oral Solid Dosage Manufacturing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oral Solid Dosage Manufacturing Market Size by Region (2020-2025)
8.4 Asia-Pacific Oral Solid Dosage Manufacturing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral Solid Dosage Manufacturing Market Size (2020-2031)
9.2 Latin America Oral Solid Dosage Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oral Solid Dosage Manufacturing Market Size by Country (2020-2025)
9.4 Latin America Oral Solid Dosage Manufacturing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Solid Dosage Manufacturing Market Size (2020-2031)
10.2 Middle East & Africa Oral Solid Dosage Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oral Solid Dosage Manufacturing Market Size by Country (2020-2025)
10.4 Middle East & Africa Oral Solid Dosage Manufacturing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CRB
11.1.1 CRB Company Details
11.1.2 CRB Business Overview
11.1.3 CRB Oral Solid Dosage Manufacturing Introduction
11.1.4 CRB Revenue in Oral Solid Dosage Manufacturing Business (2020-2025)
11.1.5 CRB Recent Development
11.2 LGM Pharma
11.2.1 LGM Pharma Company Details
11.2.2 LGM Pharma Business Overview
11.2.3 LGM Pharma Oral Solid Dosage Manufacturing Introduction
11.2.4 LGM Pharma Revenue in Oral Solid Dosage Manufacturing Business (2020-2025)
11.2.5 LGM Pharma Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Oral Solid Dosage Manufacturing Introduction
11.3.4 Pfizer Revenue in Oral Solid Dosage Manufacturing Business (2020-2025)
11.3.5 Pfizer Recent Development
11.4 Piramal Group
11.4.1 Piramal Group Company Details
11.4.2 Piramal Group Business Overview
11.4.3 Piramal Group Oral Solid Dosage Manufacturing Introduction
11.4.4 Piramal Group Revenue in Oral Solid Dosage Manufacturing Business (2020-2025)
11.4.5 Piramal Group Recent Development
11.5 Avara Pharmaceutical Services
11.5.1 Avara Pharmaceutical Services Company Details
11.5.2 Avara Pharmaceutical Services Business Overview
11.5.3 Avara Pharmaceutical Services Oral Solid Dosage Manufacturing Introduction
11.5.4 Avara Pharmaceutical Services Revenue in Oral Solid Dosage Manufacturing Business (2020-2025)
11.5.5 Avara Pharmaceutical Services Recent Development
11.6 Alcami
11.6.1 Alcami Company Details
11.6.2 Alcami Business Overview
11.6.3 Alcami Oral Solid Dosage Manufacturing Introduction
11.6.4 Alcami Revenue in Oral Solid Dosage Manufacturing Business (2020-2025)
11.6.5 Alcami Recent Development
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Details
11.7.2 Thermo Fisher Scientific Business Overview
11.7.3 Thermo Fisher Scientific Oral Solid Dosage Manufacturing Introduction
11.7.4 Thermo Fisher Scientific Revenue in Oral Solid Dosage Manufacturing Business (2020-2025)
11.7.5 Thermo Fisher Scientific Recent Development
11.8 Recipharm
11.8.1 Recipharm Company Details
11.8.2 Recipharm Business Overview
11.8.3 Recipharm Oral Solid Dosage Manufacturing Introduction
11.8.4 Recipharm Revenue in Oral Solid Dosage Manufacturing Business (2020-2025)
11.8.5 Recipharm Recent Development
11.9 Metrics Contract Services
11.9.1 Metrics Contract Services Company Details
11.9.2 Metrics Contract Services Business Overview
11.9.3 Metrics Contract Services Oral Solid Dosage Manufacturing Introduction
11.9.4 Metrics Contract Services Revenue in Oral Solid Dosage Manufacturing Business (2020-2025)
11.9.5 Metrics Contract Services Recent Development
11.10 BOC Sciences
11.10.1 BOC Sciences Company Details
11.10.2 BOC Sciences Business Overview
11.10.3 BOC Sciences Oral Solid Dosage Manufacturing Introduction
11.10.4 BOC Sciences Revenue in Oral Solid Dosage Manufacturing Business (2020-2025)
11.10.5 BOC Sciences Recent Development
11.11 Societal CDMO
11.11.1 Societal CDMO Company Details
11.11.2 Societal CDMO Business Overview
11.11.3 Societal CDMO Oral Solid Dosage Manufacturing Introduction
11.11.4 Societal CDMO Revenue in Oral Solid Dosage Manufacturing Business (2020-2025)
11.11.5 Societal CDMO Recent Development
11.12 DFE Pharma
11.12.1 DFE Pharma Company Details
11.12.2 DFE Pharma Business Overview
11.12.3 DFE Pharma Oral Solid Dosage Manufacturing Introduction
11.12.4 DFE Pharma Revenue in Oral Solid Dosage Manufacturing Business (2020-2025)
11.12.5 DFE Pharma Recent Development
11.13 NNE
11.13.1 NNE Company Details
11.13.2 NNE Business Overview
11.13.3 NNE Oral Solid Dosage Manufacturing Introduction
11.13.4 NNE Revenue in Oral Solid Dosage Manufacturing Business (2020-2025)
11.13.5 NNE Recent Development
11.14 Pharma Access
11.14.1 Pharma Access Company Details
11.14.2 Pharma Access Business Overview
11.14.3 Pharma Access Oral Solid Dosage Manufacturing Introduction
11.14.4 Pharma Access Revenue in Oral Solid Dosage Manufacturing Business (2020-2025)
11.14.5 Pharma Access Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Oral Solid Dosage Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Wet Granulation
 Table 3. Key Players of Dry Granulation
 Table 4. Key Players of Direct Compression
 Table 5. Key Players of Particle Coating
 Table 6. Key Players of Other
 Table 7. Global Oral Solid Dosage Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Oral Solid Dosage Manufacturing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Oral Solid Dosage Manufacturing Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Oral Solid Dosage Manufacturing Market Share by Region (2020-2025)
 Table 11. Global Oral Solid Dosage Manufacturing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Oral Solid Dosage Manufacturing Market Share by Region (2026-2031)
 Table 13. Oral Solid Dosage Manufacturing Market Trends
 Table 14. Oral Solid Dosage Manufacturing Market Drivers
 Table 15. Oral Solid Dosage Manufacturing Market Challenges
 Table 16. Oral Solid Dosage Manufacturing Market Restraints
 Table 17. Global Oral Solid Dosage Manufacturing Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Oral Solid Dosage Manufacturing Market Share by Players (2020-2025)
 Table 19. Global Top Oral Solid Dosage Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Solid Dosage Manufacturing as of 2024)
 Table 20. Ranking of Global Top Oral Solid Dosage Manufacturing Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Oral Solid Dosage Manufacturing Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Oral Solid Dosage Manufacturing, Headquarters and Area Served
 Table 23. Global Key Players of Oral Solid Dosage Manufacturing, Product and Application
 Table 24. Global Key Players of Oral Solid Dosage Manufacturing, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Oral Solid Dosage Manufacturing Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Oral Solid Dosage Manufacturing Revenue Market Share by Type (2020-2025)
 Table 28. Global Oral Solid Dosage Manufacturing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Oral Solid Dosage Manufacturing Revenue Market Share by Type (2026-2031)
 Table 30. Global Oral Solid Dosage Manufacturing Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Oral Solid Dosage Manufacturing Revenue Market Share by Application (2020-2025)
 Table 32. Global Oral Solid Dosage Manufacturing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Oral Solid Dosage Manufacturing Revenue Market Share by Application (2026-2031)
 Table 34. North America Oral Solid Dosage Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Oral Solid Dosage Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Oral Solid Dosage Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Oral Solid Dosage Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Oral Solid Dosage Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Oral Solid Dosage Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Oral Solid Dosage Manufacturing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Oral Solid Dosage Manufacturing Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Oral Solid Dosage Manufacturing Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Oral Solid Dosage Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Oral Solid Dosage Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Oral Solid Dosage Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Oral Solid Dosage Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Oral Solid Dosage Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Oral Solid Dosage Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 49. CRB Company Details
 Table 50. CRB Business Overview
 Table 51. CRB Oral Solid Dosage Manufacturing Product
 Table 52. CRB Revenue in Oral Solid Dosage Manufacturing Business (2020-2025) & (US$ Million)
 Table 53. CRB Recent Development
 Table 54. LGM Pharma Company Details
 Table 55. LGM Pharma Business Overview
 Table 56. LGM Pharma Oral Solid Dosage Manufacturing Product
 Table 57. LGM Pharma Revenue in Oral Solid Dosage Manufacturing Business (2020-2025) & (US$ Million)
 Table 58. LGM Pharma Recent Development
 Table 59. Pfizer Company Details
 Table 60. Pfizer Business Overview
 Table 61. Pfizer Oral Solid Dosage Manufacturing Product
 Table 62. Pfizer Revenue in Oral Solid Dosage Manufacturing Business (2020-2025) & (US$ Million)
 Table 63. Pfizer Recent Development
 Table 64. Piramal Group Company Details
 Table 65. Piramal Group Business Overview
 Table 66. Piramal Group Oral Solid Dosage Manufacturing Product
 Table 67. Piramal Group Revenue in Oral Solid Dosage Manufacturing Business (2020-2025) & (US$ Million)
 Table 68. Piramal Group Recent Development
 Table 69. Avara Pharmaceutical Services Company Details
 Table 70. Avara Pharmaceutical Services Business Overview
 Table 71. Avara Pharmaceutical Services Oral Solid Dosage Manufacturing Product
 Table 72. Avara Pharmaceutical Services Revenue in Oral Solid Dosage Manufacturing Business (2020-2025) & (US$ Million)
 Table 73. Avara Pharmaceutical Services Recent Development
 Table 74. Alcami Company Details
 Table 75. Alcami Business Overview
 Table 76. Alcami Oral Solid Dosage Manufacturing Product
 Table 77. Alcami Revenue in Oral Solid Dosage Manufacturing Business (2020-2025) & (US$ Million)
 Table 78. Alcami Recent Development
 Table 79. Thermo Fisher Scientific Company Details
 Table 80. Thermo Fisher Scientific Business Overview
 Table 81. Thermo Fisher Scientific Oral Solid Dosage Manufacturing Product
 Table 82. Thermo Fisher Scientific Revenue in Oral Solid Dosage Manufacturing Business (2020-2025) & (US$ Million)
 Table 83. Thermo Fisher Scientific Recent Development
 Table 84. Recipharm Company Details
 Table 85. Recipharm Business Overview
 Table 86. Recipharm Oral Solid Dosage Manufacturing Product
 Table 87. Recipharm Revenue in Oral Solid Dosage Manufacturing Business (2020-2025) & (US$ Million)
 Table 88. Recipharm Recent Development
 Table 89. Metrics Contract Services Company Details
 Table 90. Metrics Contract Services Business Overview
 Table 91. Metrics Contract Services Oral Solid Dosage Manufacturing Product
 Table 92. Metrics Contract Services Revenue in Oral Solid Dosage Manufacturing Business (2020-2025) & (US$ Million)
 Table 93. Metrics Contract Services Recent Development
 Table 94. BOC Sciences Company Details
 Table 95. BOC Sciences Business Overview
 Table 96. BOC Sciences Oral Solid Dosage Manufacturing Product
 Table 97. BOC Sciences Revenue in Oral Solid Dosage Manufacturing Business (2020-2025) & (US$ Million)
 Table 98. BOC Sciences Recent Development
 Table 99. Societal CDMO Company Details
 Table 100. Societal CDMO Business Overview
 Table 101. Societal CDMO Oral Solid Dosage Manufacturing Product
 Table 102. Societal CDMO Revenue in Oral Solid Dosage Manufacturing Business (2020-2025) & (US$ Million)
 Table 103. Societal CDMO Recent Development
 Table 104. DFE Pharma Company Details
 Table 105. DFE Pharma Business Overview
 Table 106. DFE Pharma Oral Solid Dosage Manufacturing Product
 Table 107. DFE Pharma Revenue in Oral Solid Dosage Manufacturing Business (2020-2025) & (US$ Million)
 Table 108. DFE Pharma Recent Development
 Table 109. NNE Company Details
 Table 110. NNE Business Overview
 Table 111. NNE Oral Solid Dosage Manufacturing Product
 Table 112. NNE Revenue in Oral Solid Dosage Manufacturing Business (2020-2025) & (US$ Million)
 Table 113. NNE Recent Development
 Table 114. Pharma Access Company Details
 Table 115. Pharma Access Business Overview
 Table 116. Pharma Access Oral Solid Dosage Manufacturing Product
 Table 117. Pharma Access Revenue in Oral Solid Dosage Manufacturing Business (2020-2025) & (US$ Million)
 Table 118. Pharma Access Recent Development
 Table 119. Research Programs/Design for This Report
 Table 120. Key Data Information from Secondary Sources
 Table 121. Key Data Information from Primary Sources
 Table 122. Authors List of This Report


List of Figures
 Figure 1. Oral Solid Dosage Manufacturing Picture
 Figure 2. Global Oral Solid Dosage Manufacturing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Oral Solid Dosage Manufacturing Market Share by Type: 2024 VS 2031
 Figure 4. Wet Granulation Features
 Figure 5. Dry Granulation Features
 Figure 6. Direct Compression Features
 Figure 7. Particle Coating Features
 Figure 8. Other Features
 Figure 9. Global Oral Solid Dosage Manufacturing Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Oral Solid Dosage Manufacturing Market Share by Application: 2024 VS 2031
 Figure 11. Drug Formulation Development Case Studies
 Figure 12. Formulation Production Case Studies
 Figure 13. Oral Solid Dosage Manufacturing Report Years Considered
 Figure 14. Global Oral Solid Dosage Manufacturing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Oral Solid Dosage Manufacturing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Oral Solid Dosage Manufacturing Market Share by Region: 2024 VS 2031
 Figure 17. Global Oral Solid Dosage Manufacturing Market Share by Players in 2024
 Figure 18. Global Top Oral Solid Dosage Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Solid Dosage Manufacturing as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Oral Solid Dosage Manufacturing Revenue in 2024
 Figure 20. North America Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Oral Solid Dosage Manufacturing Market Share by Country (2020-2031)
 Figure 22. United States Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Oral Solid Dosage Manufacturing Market Share by Country (2020-2031)
 Figure 26. Germany Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Oral Solid Dosage Manufacturing Market Share by Region (2020-2031)
 Figure 34. China Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Oral Solid Dosage Manufacturing Market Share by Country (2020-2031)
 Figure 42. Mexico Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Oral Solid Dosage Manufacturing Market Share by Country (2020-2031)
 Figure 46. Turkey Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Oral Solid Dosage Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. CRB Revenue Growth Rate in Oral Solid Dosage Manufacturing Business (2020-2025)
 Figure 50. LGM Pharma Revenue Growth Rate in Oral Solid Dosage Manufacturing Business (2020-2025)
 Figure 51. Pfizer Revenue Growth Rate in Oral Solid Dosage Manufacturing Business (2020-2025)
 Figure 52. Piramal Group Revenue Growth Rate in Oral Solid Dosage Manufacturing Business (2020-2025)
 Figure 53. Avara Pharmaceutical Services Revenue Growth Rate in Oral Solid Dosage Manufacturing Business (2020-2025)
 Figure 54. Alcami Revenue Growth Rate in Oral Solid Dosage Manufacturing Business (2020-2025)
 Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Oral Solid Dosage Manufacturing Business (2020-2025)
 Figure 56. Recipharm Revenue Growth Rate in Oral Solid Dosage Manufacturing Business (2020-2025)
 Figure 57. Metrics Contract Services Revenue Growth Rate in Oral Solid Dosage Manufacturing Business (2020-2025)
 Figure 58. BOC Sciences Revenue Growth Rate in Oral Solid Dosage Manufacturing Business (2020-2025)
 Figure 59. Societal CDMO Revenue Growth Rate in Oral Solid Dosage Manufacturing Business (2020-2025)
 Figure 60. DFE Pharma Revenue Growth Rate in Oral Solid Dosage Manufacturing Business (2020-2025)
 Figure 61. NNE Revenue Growth Rate in Oral Solid Dosage Manufacturing Business (2020-2025)
 Figure 62. Pharma Access Revenue Growth Rate in Oral Solid Dosage Manufacturing Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD